| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59-7939) in Healthy Subjects
|
Kubitza, Dagmar
|
|
2007
|
47 |
2 |
p. 218-226
|
artikel
|
| 2 |
Clearance of Imidapril, an Angiotensin-Converting Enzyme Inhibitor, During Hemodialysis in Hypertensive Renal Failure Patients: Comparison With Quinapril and Enalapril
|
Tsuruoka, Shuichi
|
|
2007
|
47 |
2 |
p. 259-263
|
artikel
|
| 3 |
Effect of a Single Cyclosporine Dose on the Single-Dose Pharmacokinetics of Sitagliptin (MK-0431), a Dipeptidyl Peptidase-4 Inhibitor, in Healthy Male Subjects
|
Krishna, Rajesh
|
|
2007
|
47 |
2 |
p. 165-174
|
artikel
|
| 4 |
Extended Thiopurine Metabolite Assessment During 6-Thioguanine Therapy for Immunomodulation in Crohn’s Disease
|
de Boer, N. K. H.
|
|
2007
|
47 |
2 |
p. 187-191
|
artikel
|
| 5 |
Incorporating In Vitro Information on Drug Metabolism Into Clinical Trial Simulations to Assess the Effect of CYP2D6 Polymorphism on Pharmacokinetics and Pharmacodynamics: Dextromethorphan as a Model Application
|
Dickinson, Gemma L.
|
|
2007
|
47 |
2 |
p. 175-186
|
artikel
|
| 6 |
Modeling the Exposure-Response Relationship of Etanercept in the Treatment of Patients With Chronic Moderate to Severe Plaque Psoriasis
|
Hutmacher, Matthew M.
|
|
2007
|
47 |
2 |
p. 238-248
|
artikel
|
| 7 |
Multiple-Dose Administration of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Alter the Single-Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects
|
Mistry, Goutam C.
|
|
2007
|
47 |
2 |
p. 159-164
|
artikel
|
| 8 |
NXY-059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, 3-Period Crossover Phase I Study
|
Nilsson, Dag
|
|
2007
|
47 |
2 |
p. 264-272
|
artikel
|
| 9 |
Pharmacokinetics of Maribavir, a Novel Oral Anticytomegalovirus Agent, in Subjects With Varying Degrees of Renal Impairment
|
Swan, Suzanne K.
|
|
2007
|
47 |
2 |
p. 209-217
|
artikel
|
| 10 |
Pharmacokinetics of Saquinavir With Atazanavir or Low-Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers
|
King, Jennifer R.
|
|
2007
|
47 |
2 |
p. 201-208
|
artikel
|
| 11 |
Pharmacokinetics, Safety, and Tolerability of the Oral Renin Inhibitor Aliskiren in Patients With Hepatic Impairment
|
Vaidyanathan, Sujata
|
|
2007
|
47 |
2 |
p. 192-200
|
artikel
|
| 12 |
Population Pharmacokinetics of Humanized Monoclonal Antibody HuCC49ΔCH2 and Murine Antibody CC49 in Colorectal Cancer Patients
|
Fang, Lanyan
|
|
2007
|
47 |
2 |
p. 227-237
|
artikel
|
| 13 |
Potential Interactions Between Pharmaceuticals and Natural Health Products in Canada
|
Singh, Sumeet R.
|
|
2007
|
47 |
2 |
p. 249-258
|
artikel
|
| 14 |
Selegiline Transdermal System: An Examination of the Potential for CYP450- Dependent Pharmacokinetic Interactions With 3 Psychotropic Medications
|
Azzaro, Albert J.
|
|
2007
|
47 |
2 |
p. 146-158
|
artikel
|
Tijdschrift beschrijving